Distinct histone modifications denote early stress-induced drug tolerance in cancer
View/ Open
Author
Al Emran, Abdullah
Marzese, Diego M.
Menon, Dinoop Ravindran
Stark, Mitchell S.
Torrano, Joachim
Hammerlindl, Heinz
Zhang, Gao
Brafford, Patricia
Salomon, Matthew P.
Nelson, Nellie
Hammerlindl, Sabrina
Gupta, Deepesh
Mills, Gordon B.
Lu, Yiling
Sturm, Richard A.
Hoon, Dave S. B.
Gabrielli, Brian
Herlyn, Meenhard
Schaider, Helmut
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.18632/oncotarget.23654Metadata
Show full item recordCitation
Al Emran, A., D. M. Marzese, D. R. Menon, M. S. Stark, J. Torrano, H. Hammerlindl, G. Zhang, et al. 2018. “Distinct histone modifications denote early stress-induced drug tolerance in cancer.” Oncotarget 9 (9): 8206-8222. doi:10.18632/oncotarget.23654. http://dx.doi.org/10.18632/oncotarget.23654.Abstract
Besides somatic mutations or drug efflux, epigenetic reprogramming can lead to acquired drug resistance. We recently have identified early stress-induced multi-drug tolerant cancer cells termed induced drug-tolerant cells (IDTCs). Here, IDTCs were generated using different types of cancer cell lines; melanoma, lung, breast and colon cancer. A common loss of the H3K4me3 and H3K27me3 and gain of H3K9me3 mark was observed as a significant response to drug exposure or nutrient starvation in IDTCs. These epigenetic changes were reversible upon drug holidays. Microarray, qRT-PCR and protein expression data confirmed the up-regulation of histone methyltransferases (SETDB1 and SETDB2) which contribute to the accumulation of H3K9me3 concomitantly in the different cancer types. Genome-wide studies suggest that transcriptional repression of genes is due to concordant loss of H3K4me3 and regional increment of H3K9me3. Conversely, genome-wide CpG site-specific DNA methylation showed no common changes at the IDTC state. This suggests that distinct histone methylation patterns rather than DNA methylation are driving the transition from parental to IDTCs. In addition, silencing of SETDB1/2 reversed multi drug tolerance. Alterations of histone marks in early multi-drug tolerance with an increment in H3K9me3 and loss of H3K4me3/H3K27me3 is neither exclusive for any particular stress response nor cancer type specific but rather a generic response.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823586/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:35014968
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)